vs
Immunocore Holdings plc（IMCR）与STURM RUGER & CO INC（RGR）财务数据对比。点击上方公司名可切换其他公司
STURM RUGER & CO INC的季度营收约是Immunocore Holdings plc的1.4倍（$151.1M vs $104.5M），Immunocore Holdings plc同比增速更快（24.3% vs 3.6%），STURM RUGER & CO INC自由现金流更多（$12.3M vs $-35.5M），过去两年Immunocore Holdings plc的营收复合增速更高（21.7% vs 5.1%）
Immunocore是一家处于商业化阶段的全球生物技术企业，总部位于英国牛津郡，依托可溶性T细胞受体技术深耕生物药物的研发领域，其创新技术平台为肿瘤、感染性疾病、自身免疫性疾病等多领域的新药开发提供支撑。
鲁格公司（Ruger）是总部位于美国康涅狄格州绍斯波特的枪械制造企业，除总部外，还在新罕布什尔州纽波特、北卡罗来纳州梅约丹以及亚利桑那州普雷斯科特设有生产工厂。公司由亚历山大·麦考密克·斯特姆与威廉·B·鲁格于1949年共同创立，自1969年起公开上市交易。
IMCR vs RGR — 直观对比
营收规模更大
RGR
是对方的1.4倍
$104.5M
营收增速更快
IMCR
高出20.7%
3.6%
自由现金流更多
RGR
多$47.9M
$-35.5M
两年增速更快
IMCR
近两年复合增速
5.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $104.5M | $151.1M |
| 净利润 | — | — |
| 毛利率 | 97.4% | 17.8% |
| 营业利润率 | -18.8% | 2.3% |
| 净利率 | — | — |
| 营收同比 | 24.3% | 3.6% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $-0.61 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IMCRRGR
| Q4 25 | $104.5M | $151.1M | ||
| Q3 25 | $103.7M | $126.8M | ||
| Q2 25 | $98.0M | $132.5M | ||
| Q1 25 | $93.9M | $135.7M | ||
| Q4 24 | $84.1M | $145.8M | ||
| Q3 24 | $80.2M | $122.3M | ||
| Q2 24 | $75.4M | $130.8M | ||
| Q1 24 | $70.5M | $136.8M |
净利润IMCRRGR
| Q4 25 | — | — | ||
| Q3 25 | $-177.0K | $1.6M | ||
| Q2 25 | $-10.3M | $-17.2M | ||
| Q1 25 | $5.0M | $7.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $8.7M | $4.7M | ||
| Q2 24 | $-11.6M | $8.3M | ||
| Q1 24 | $-24.4M | $7.1M |
毛利率IMCRRGR
| Q4 25 | 97.4% | 17.8% | ||
| Q3 25 | 99.5% | 15.1% | ||
| Q2 25 | 98.9% | 3.9% | ||
| Q1 25 | 99.1% | 22.0% | ||
| Q4 24 | 99.6% | 22.8% | ||
| Q3 24 | 99.4% | 18.5% | ||
| Q2 24 | 97.7% | 22.3% | ||
| Q1 24 | 99.7% | 21.5% |
营业利润率IMCRRGR
| Q4 25 | -18.8% | 2.3% | ||
| Q3 25 | -6.9% | -2.7% | ||
| Q2 25 | -15.2% | -15.6% | ||
| Q1 25 | -3.9% | 6.2% | ||
| Q4 24 | -23.1% | 7.8% | ||
| Q3 24 | -10.6% | 3.1% | ||
| Q2 24 | -21.2% | 6.9% | ||
| Q1 24 | -37.6% | 5.5% |
净利率IMCRRGR
| Q4 25 | — | — | ||
| Q3 25 | -0.2% | 1.2% | ||
| Q2 25 | -10.5% | -13.0% | ||
| Q1 25 | 5.4% | 5.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.9% | 3.9% | ||
| Q2 24 | -15.4% | 6.3% | ||
| Q1 24 | -34.7% | 5.2% |
每股收益（稀释后）IMCRRGR
| Q4 25 | $-0.61 | $0.22 | ||
| Q3 25 | $0.00 | $0.10 | ||
| Q2 25 | $-0.20 | $-1.05 | ||
| Q1 25 | $0.10 | $0.46 | ||
| Q4 24 | $-0.47 | $0.62 | ||
| Q3 24 | $0.17 | $0.28 | ||
| Q2 24 | $-0.23 | $0.47 | ||
| Q1 24 | $-0.49 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $864.2M | $92.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $381.0M | $283.8M |
| 总资产 | $1.1B | $342.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IMCRRGR
| Q4 25 | $864.2M | $92.5M | ||
| Q3 25 | $892.4M | $80.8M | ||
| Q2 25 | $882.8M | $101.4M | ||
| Q1 25 | $837.0M | $108.3M | ||
| Q4 24 | $820.4M | $105.5M | ||
| Q3 24 | $901.3M | $96.0M | ||
| Q2 24 | $859.6M | $105.6M | ||
| Q1 24 | $832.8M | $115.3M |
总债务IMCRRGR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $438.7M | — | ||
| Q2 24 | $452.5M | — | ||
| Q1 24 | $452.5M | — |
股东权益IMCRRGR
| Q4 25 | $381.0M | $283.8M | ||
| Q3 25 | $396.6M | $279.6M | ||
| Q2 25 | $388.5M | $289.3M | ||
| Q1 25 | $378.5M | $321.5M | ||
| Q4 24 | $360.7M | $319.6M | ||
| Q3 24 | $377.8M | $314.9M | ||
| Q2 24 | $359.1M | $321.5M | ||
| Q1 24 | $359.5M | $332.0M |
总资产IMCRRGR
| Q4 25 | $1.1B | $342.0M | ||
| Q3 25 | $1.1B | $342.3M | ||
| Q2 25 | $1.1B | $349.5M | ||
| Q1 25 | $1.0B | $379.0M | ||
| Q4 24 | $1.0B | $384.0M | ||
| Q3 24 | $1.1B | $373.5M | ||
| Q2 24 | $1.0B | $376.7M | ||
| Q1 24 | $994.0M | $385.0M |
负债/权益比IMCRRGR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.16× | — | ||
| Q2 24 | 1.26× | — | ||
| Q1 24 | 1.26× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.7M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $-35.5M | $12.3M |
| 自由现金流率自由现金流/营收 | -34.0% | 8.2% |
| 资本支出强度资本支出/营收 | 2.8% | 2.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-15.1M | $38.5M |
8季度趋势，按日历期对齐
经营现金流IMCRRGR
| Q4 25 | $-32.7M | $15.5M | ||
| Q3 25 | $-4.5M | $12.9M | ||
| Q2 25 | $26.0M | $14.7M | ||
| Q1 25 | $435.0K | $11.1M | ||
| Q4 24 | $-14.0M | $20.0M | ||
| Q3 24 | $21.1M | $9.4M | ||
| Q2 24 | $23.5M | $18.7M | ||
| Q1 24 | $-4.6M | $7.3M |
自由现金流IMCRRGR
| Q4 25 | $-35.5M | $12.3M | ||
| Q3 25 | $-5.2M | $7.0M | ||
| Q2 25 | $25.6M | $9.1M | ||
| Q1 25 | $137.0K | $10.0M | ||
| Q4 24 | $-17.5M | $16.4M | ||
| Q3 24 | $20.3M | $2.6M | ||
| Q2 24 | $23.1M | $10.1M | ||
| Q1 24 | $-5.0M | $5.6M |
自由现金流率IMCRRGR
| Q4 25 | -34.0% | 8.2% | ||
| Q3 25 | -5.0% | 5.5% | ||
| Q2 25 | 26.1% | 6.9% | ||
| Q1 25 | 0.1% | 7.4% | ||
| Q4 24 | -20.9% | 11.2% | ||
| Q3 24 | 25.3% | 2.1% | ||
| Q2 24 | 30.7% | 7.7% | ||
| Q1 24 | -7.1% | 4.1% |
资本支出强度IMCRRGR
| Q4 25 | 2.8% | 2.1% | ||
| Q3 25 | 0.7% | 4.6% | ||
| Q2 25 | 0.4% | 4.2% | ||
| Q1 25 | 0.3% | 0.8% | ||
| Q4 24 | 4.3% | 2.5% | ||
| Q3 24 | 1.0% | 5.5% | ||
| Q2 24 | 0.4% | 6.6% | ||
| Q1 24 | 0.6% | 1.3% |
现金转化率IMCRRGR
| Q4 25 | — | — | ||
| Q3 25 | — | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.09× | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.42× | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IMCR
暂无分部数据
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
